SynthesisFrontiers in immunology2024

Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levels.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.